🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Todd W. Bauer

University of Virginia Health System

ORCID: 0000-0002-9516-1848
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells”.

Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.25.112896
N/A
0DataRank · unranked
7 citations

Jiekun Yang, Sara J. Adair, Cem Kuscu, Kyung Yong Lee, William J. Kane +9 more

Automated biophysical classification of apoptotic pancreatic cancer cell subpopulations by using machine learning approaches with impedance cytometry

Lab on a Chip(2022)10.1039/d2lc00304j
N/A
0DataRank · unranked
59 citations

Armita Salahi, Sara J. Adair, John H. Moore, Todd W. Bauer, Nathan S. Swami +1 more

A histone methylation-MAPK signaling axis drives durable epithelial-mesenchymal transition in hypoxic pancreas cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.19.512869
N/A
0DataRank · unranked
3 citations

Paul J. Myers, Sara J. Adair, Jason R. Pitarresi, Shiv K. Sah‐Teli, Logan A. Campbell +14 more

Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007586
N/A
0DataRank · unranked
35 citations

Gina R. Petroni, Todd W. Bauer, Matthew J. Reilley, Brian M. Wolpin, Chee‐Chee Stucky +14 more

PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1444
N/A
0DataRank · unranked
27 citations

Patrick J. Lenehan, Victoire Cardot‐Ruffino, Andressa Dias Costa, Matthew H. G. Katz, Todd W. Bauer +16 more

Dielectrophoretic enrichment of live chemo-resistant circulating-like pancreatic cancer cells from media of drug-treated adherent cultures of solid tumors

Lab on a Chip(2023)10.1039/d3lc00804e
N/A
0DataRank · unranked
20 citations

Javad Jarmoshti, Abdullah‐Bin Siddique, Sara J. Adair, Karina Torres‐Castro, Carlos Honrado +3 more

Supervised learning on impedance cytometry data for label-free biophysical distinction of pancreatic cancer cells versus their associated fibroblasts under gemcitabine treatment

Biosensors and Bioelectronics(2023)10.1016/j.bios.2023.115262
N/A
0DataRank · unranked
24 citations

Carlos Honrado, John H. Moore, Sara J. Adair, Todd W. Bauer, Nathan S. Swami +1 more

Survival benefit associated with screening of patients at elevated risk for pancreatic cancer

Journal of Surgical Oncology(2024)10.1002/jso.27784
N/A
0DataRank · unranked
2 citations

Kathleen Haden, Elizabeth Martin, Vanessa M. Shami, Andrew Y. Wang, Daniel S. Strand +7 more

Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugates

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008430
N/A
0DataRank · unranked
1 citations

Jagathpala Shetty, Christine Tran, Walter C. Olson, Mriganka Mandal, Bhupal Ban +6 more

PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic Cancer

Biomolecules(2025)10.3390/biom15070948
N/A
0DataRank · unranked
1 citations

William J. Kane, Sara J. Adair, Sarbajeet Nagdas, Denis Liu, Todd W. Bauer +1 more